drugset
drugset / Trial / NCT05445089

Study to Verify the Effectiveness and Safety of Isothymol or Carvacrol Compound Against SARS-CoV-2 in COVID-19 Patients

NCT05445089 ↗

Phase 2/3 Completed 600 enrolled Venezuelan Institute for Scientific Research
RandomizedParallel-groupSingle-blindTreatment

Summary

• Check the efficacy, safety and tolerability of the compound Modified isothymol against the SARS-CoV-2 agent in patients COVID-19.

Timeline

Start
2020-08-01
Primary completion
2020-11-01
Completion
2020-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvacrol Small molecule 6 mg/ml Oral

Indications

COVID-19 acute respiratory distress syndrome pneumonia